| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Heron Therapeutics Inc. (LSE: 0J4V)
0J4V Technical Analysis
4
| As on 12th Nov 2024 0J4V STOCK Price closed @ 1.30 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.74 & Strong Sell for SHORT-TERM with Stoploss of 1.71 we also expect STOCK to react on Following IMPORTANT LEVELS. |
0J4VSTOCK Price
| Open | 1.17 | Change | Price | % |
| High | 1.50 | 1 Day | -0.50 | -27.78 |
| Low | 1.05 | 1 Week | -0.46 | -26.14 |
| Close | 1.30 | 1 Month | -0.67 | -34.01 |
| Volume | 33432 | 1 Year | -0.20 | -13.33 |
| 52 Week High 3.80 | 52 Week Low 0.54 | ||||
LSE UK Most Active Stocks
| NTOG | 0.02 | 0.00% |
| CPX | 0.14 | 7.69% |
| MSMN | 0.04 | 0.00% |
| VELA | 0.01 | % |
| TRP | 0.03 | % |
| SCGL | 0.27 | 92.86% |
| DKE | 0.15 | 0.00% |
| NNN | 0.09 | 50.00% |
| DMTR | 0.03 | 0.00% |
| VAST | 0.08 | 14.29% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| 0J4V Daily Charts |
0J4V Intraday Charts |
Whats New @ Bazaartrend |
0J4V Free Analysis |
|
|
0J4V Important Levels Intraday
| RESISTANCE | 2.17 |
| RESISTANCE | 1.89 |
| RESISTANCE | 1.72 |
| RESISTANCE | 1.55 |
| SUPPORT | 1.05 |
| SUPPORT | 0.88 |
| SUPPORT | 0.71 |
| SUPPORT | 0.43 |
0J4V Forecast November 2024
| 4th UP Forecast | 2.13 |
| 3rd UP Forecast | 1.86 |
| 2nd UP Forecast | 1.7 |
| 1st UP Forecast | 1.53 |
| 1st DOWN Forecast | 1.07 |
| 2nd DOWN Forecast | 0.9 |
| 3rd DOWN Forecast | 0.74 |
| 4th DOWN Forecast | 0.47 |
0J4V Weekly Forecast
| 4th UP Forecast | 4.04 |
| 3rd UP Forecast | 3.16 |
| 2nd UP Forecast | 2.62 |
| 1st UP Forecast | 2.07 |
| 1st DOWN Forecast | 0.53 |
| 2nd DOWN Forecast | -0.02 |
| 3rd DOWN Forecast | -0.56 |
| 4th DOWN Forecast | -1.44 |
0J4V Forecast2024
| 4th UP Forecast | 7.81 |
| 3rd UP Forecast | 5.72 |
| 2nd UP Forecast | 4.43 |
| 1st UP Forecast | 3.14 |
| 1st DOWN Forecast | -0.54 |
| 2nd DOWN Forecast | -1.83 |
| 3rd DOWN Forecast | -3.12 |
| 4th DOWN Forecast | -5.21 |
Heron Therapeutics Inc. ( LSE UK Symbol : 0J4V )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
0J4V Business Profile
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing HTX-011, an investigational, dual-acting, and fixed-dose combination of the local anesthetic bupivacaine with a low dose of the nonsteroidal anti-inflammatory drug meloxicam, which is in Phase III clinical trials for pain management; and HTX-034, which is in Phase Ib/II clinical trials for postoperative pain management. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California. Address: 4242 Campus Point Court, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service